Stephen L. Huhn

Stephen L. Huhn

Former Chief Medical Officer and Senior Vice President of Clinical DevelopmentatContineum Therapeutics· In the 2024 proxy

Pay in FY2024

Stephen L. Huhn was paid $2.1M in FY2024 (Dec).

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Contineum Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Contineum TherapeuticsPublic company · 2 yr
    • Former Chief Medical Officer and Senior Vice President of Clinical Development2024 – Present · 2 yrStock in role -41%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?